Key Record Dates
ClinicalTrials.gov Identifier: | NCT03343054 |
---|---|
Brief Title: | A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors |
First Submitted : | November 11, 2017 |
First Submitted that Met QC Criteria : | November 11, 2017 |
First Posted : | November 17, 2017 |
Results First Submitted : | December 20, 2021 |
Results First Submitted that Met QC Criteria : | December 20, 2021 |
Results First Posted : | March 10, 2022 |
Last Update Submitted that Met QC Criteria : | September 19, 2023 |
Last Update Posted : | September 21, 2023 |